【24h】

Making a difference

机译:有所作为

获取原文
获取原文并翻译 | 示例
       

摘要

When Mediver AB, a Swedish group focused on developing new substances for treating infectious diseases, such as AIDS, shingles, and Herpes, needed a subsidiary with related products and plenty of market experience, it turned to Clean ChemicalSweden. The acquisition has been positive for both companies. Since the take-over, CCS has tapped into Mediver's research and development capabilities to reach new customers. On the other hand, as a subsidiary in Mediver, CCS develops, produces, andmarkets skin-care and pharmaceutical products for many of these ailments. With a slew of innovative products new on the market, CCS is having an impact in Europe and the USA.
机译:瑞典的Mediver AB是一家致力于开发用于治疗诸如AIDS,带状疱疹和疱疹等传染病的新物质的瑞典集团,需要一家拥有相关产品和丰富市场经验的子公司时,它转向了Clean ChemicalSweden。此次收购对两家公司都是积极的。自接管以来,CCS充分利用了Mediver的研发能力来吸引新客户。另一方面,作为Mediver的子公司,CCS为许多此类疾病开发,生产和销售皮肤护理和药品。随着市场上大量新产品的创新,CCS在欧洲和美国都产生了影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号